Ventilator associated pneumonia - Revision history

Elcatracho: /* Prophylaxis */

2022-04-26T05:26:14Z

Prophylaxis

← Older revision		Revision as of 05:26, 26 April 2022
Line 50:		Line 50:

	==Prophylaxis==		==Prophylaxis==
	*VAP rates decreased with chlorhexidine oral decontamination		*VAP rates decreased with [[chlorhexidine]] oral decontamination
	*Head of bed at 30 degrees decreases passive aspiration and VAP<ref>Drakulovic, M. B., Torres, A., Bauer, T. T., Nicolas, J. M., Nogué, S. and Ferrer, M. (1999) ‘Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial’, The Lancet, 354(9193), pp. 1851–1858.</ref>		*Head of bed at 30 degrees decreases passive aspiration and VAP<ref>Drakulovic, M. B., Torres, A., Bauer, T. T., Nicolas, J. M., Nogué, S. and Ferrer, M. (1999) ‘Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial’, The Lancet, 354(9193), pp. 1851–1858.</ref>
	*Stress ulcer prophylaxis likely has small increase in VAP rates		*Stress ulcer prophylaxis likely has small increase in VAP rates

ClaireLewis at 16:07, 27 September 2019

2019-09-27T16:07:12Z

← Older revision		Revision as of 16:07, 27 September 2019
Line 7:		Line 7:
	***[[Acinetobacter sp.]]		***[[Acinetobacter sp.]]
	===Definition===		===Definition===
	*Pneumonia ~~occuring~~ >48 hours after intubation and mechanical ventilation		*[[Pneumonia]] occurring >48 hours after intubation and mechanical ventilation

	==Clinical Features==		==Clinical Features==
	*Fever > 38.3		*[[Fever]] > 38.3
	*Increased FiO2 requirement		*[[hypoxia\|Increased FiO2 requirement]]
	*Worsening sepsis		*Worsening [[sepsis]]
	*Leukocyte count > 10,000 or <5,000		*[[Leukocytosis\|Leukocyte]] count > 10,000 or <5,000
	*New infiltrate on CXR		*New infiltrate on [[CXR]]
	**Difficult to diagnose with pre-existing infiltrates		**Difficult to diagnose with pre-existing infiltrates

Line 26:		Line 26:
	*[[Tension pneumothorax]]		*[[Tension pneumothorax]]
	*[[Obstruction]]		*[[Obstruction]]
	*Sepsis from other source		*[[Sepsis]] from other source
	*[[Heart failure]]		*[[Heart failure]]
	*[[Tamponade]]		*[[Tamponade]]
Line 37:		Line 37:
	*[[CXR]]		*[[CXR]]
	*CBC		*CBC
	*ABG		*[[ABG]]
	*Lactate		*[[Lactate]]
	*Blood cultures		*Blood cultures
	*BAL culture		*BAL culture

Mholtz: Text replacement - "OR" to "'''OR'''"

2017-05-31T01:35:59Z

Text replacement - "OR" to "'''OR'''"

← Older revision		Revision as of 01:35, 31 May 2017
Line 45:		Line 45:

	==Management==		==Management==
	*[[Cefipime]], [[Imipenem]], OR [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]		*[[Cefipime]], [[Imipenem]], '''OR''' [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]
	*[[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]		*[[Cefipime]], [[imipenem]], '''OR''' [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]
	*[[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[cipro]]/[[levo]]		*[[Cefipime]], [[imipenem]], '''OR''' [[piperacillin-tazobactam]] + [[gent]] + [[cipro]]/[[levo]]

	==Prophylaxis==		==Prophylaxis==

Rossdonaldson1: Text replacement - "CXR" to "CXR"

2016-09-09T15:40:19Z

Text replacement - "*CXR" to "*CXR"

← Older revision		Revision as of 15:40, 9 September 2016
Line 35:		Line 35:
	==Evaluation==		==Evaluation==
	*No widely accepted diagnostic criteria		*No widely accepted diagnostic criteria
	*CXR		*[[CXR]]
	*CBC		*CBC
	*ABG		*ABG

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-26T15:17:53Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 15:17, 26 July 2016
Line 33:		Line 33:
	*[[Abdominal compartment syndrome]]		*[[Abdominal compartment syndrome]]

	==~~Diagnosis~~==		==Evaluation==
	*No widely accepted diagnostic criteria		*No widely accepted diagnostic criteria
	*CXR		*CXR

Neil.m.young: Text replacement - "* " to "*"

2016-07-10T07:26:41Z

Text replacement - "* " to "*"

← Older revision		Revision as of 07:26, 10 July 2016
Line 45:		Line 45:

	==Management==		==Management==
	* [[Cefipime]], [[Imipenem]], OR [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]		*[[Cefipime]], [[Imipenem]], OR [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]
	* [[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]		*[[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]
	* [[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[cipro]]/[[levo]]		*[[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[cipro]]/[[levo]]

	==Prophylaxis==		==Prophylaxis==

Neil.m.young: Text replacement - "==Treatment==" to "==Management=="

2016-07-10T07:19:03Z

Text replacement - "==Treatment==" to "==Management=="

← Older revision		Revision as of 07:19, 10 July 2016
Line 44:		Line 44:
	*Pleural effusion culture		*Pleural effusion culture

	==~~Treatment~~==		==Management==
	* [[Cefipime]], [[Imipenem]], OR [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]		* [[Cefipime]], [[Imipenem]], OR [[Piperacillin/Tazobactam]] + IV [[cipro]]/[[levo]]
	* [[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]		* [[Cefipime]], [[imipenem]], OR [[piperacillin-tazobactam]] + [[gent]] + [[azithromycin]]

Ostermayer: Text replacement - "Category:Pulm" to "Category:Pulmonary"

2016-03-22T16:11:38Z

Text replacement - "Category:Pulm" to "Category:Pulmonary"

← Older revision		Revision as of 16:11, 22 March 2016
Line 60:		Line 60:
	<references/>		<references/>

	[[Category:ID]] [[Category:~~Pulm~~]] [[Category:Critical Care]]		[[Category:ID]] [[Category:Pulmonary]] [[Category:Critical Care]]

Kian: added reference

2015-06-18T20:03:16Z

added reference

← Older revision		Revision as of 20:03, 18 June 2015
Line 51:		Line 51:
	==Prophylaxis==		==Prophylaxis==
	*VAP rates decreased with chlorhexidine oral decontamination		*VAP rates decreased with chlorhexidine oral decontamination
	*Head of bed at 30 degrees decreases passive aspiration and VAP		*Head of bed at 30 degrees decreases passive aspiration and VAP<ref>Drakulovic, M. B., Torres, A., Bauer, T. T., Nicolas, J. M., Nogué, S. and Ferrer, M. (1999) ‘Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial’, The Lancet, 354(9193), pp. 1851–1858.</ref>
	*Stress ulcer prophylaxis likely has small increase in VAP rates		*Stress ulcer prophylaxis likely has small increase in VAP rates

Rossdonaldson1 at 04:30, 18 June 2015

2015-06-18T04:30:22Z

@@ Line 16: / Line 16: @@
 *New infiltrate on CXR
 **Difficult to diagnose with pre-existing infiltrates
 ==Differential Diagnosis==
@@ Line 43: / Line 32: @@
 *[[MI]]
 *[[Abdominal compartment syndrome]]
 ==Treatment==